Health & Nutrition - Netzender

Health & Nutrition

Danaher stock fails to rise on solid earnings — leading us to question what's next

Danaher stock fails to rise on solid earnings — leading us to question...

7 months ago 14

How to Beat Heart Disease Before It Starts

How to Beat Heart Disease Before It Starts

7 months ago 14

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

What obesity drugmakers see next in the market: More pills, easier acc...

7 months ago 13

Is Fasting an Effective Treatment for Diabetes?

Is Fasting an Effective Treatment for Diabetes?

7 months ago 11

468x60 AD AFTER 4 POSTS

OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion

OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 bill...

7 months ago 11

Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s

Healthy Returns: Structure Therapeutics CEO on its obesity pill, combi...

7 months ago 12

Amazon launches AI health-care tool for One Medical members

Amazon launches AI health-care tool for One Medical members

7 months ago 12

Amazon launches AI health-care tool for One Medical members

Amazon launches AI health-care tool for One Medical members

7 months ago 11

468x60 AD AFTER 4 POSTS

Another alliance of health care and AI signals why pharma stocks should be back in favor

Another alliance of health care and AI signals why pharma stocks shoul...

7 months ago 12

Another alliance of health care and AI signals why pharma stocks should be back in favor

Another alliance of health care and AI signals why pharma stocks shoul...

7 months ago 12

All About Allulose

All About Allulose

7 months ago 12

Novo Nordisk shares rise 8% after Wegovy obesity pill has 'solid' launch

Novo Nordisk shares rise 8% after Wegovy obesity pill has 'solid' laun...

7 months ago 13

468x60 AD AFTER 4 POSTS

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights ...

7 months ago 11

Making U.S. biotech more competitive with China's could help rare disease patients, experts say

Making U.S. biotech more competitive with China's could help rare dise...

7 months ago 12

Making U.S. biotech more competitive with China's could help rare disease patients, experts say

Making U.S. biotech more competitive with China's could help rare dise...

7 months ago 12